title: Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation.
authors: Roland
authors: R
authors: Fenk
authors: Florian
authors: F
authors: Neubauer
authors: Ingmar
authors: I
authors: Bruns
authors: Thomas
authors: T
authors: Schröder
authors: Ulrich
authors: U
authors: Germing
authors: Rainer
authors: R
authors: Haas
authors: Guido
authors: G
authors: Kobbe
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D016609:Neoplasms, Second Primary; D012189:Retrospective Studies